FDA approves Ortho Development’s Ovation Tribute hip stem

9 April 2014 (Last Updated April 9th, 2014 18:30)

Ortho Development has obtained approval from the US Food and Drug Administration (FDA) for its Ovation Tribute hip stem that is intended for cementless use in total hip replacement and hemiarthroplasty procedures.

Image

Ortho Development has obtained approval from the US Food and Drug Administration (FDA) for its Ovation Tribute hip stem that is intended for cementless use in total hip replacement and hemiarthroplasty procedures.

The Ovation Tribute hip stem, a femoral hip prosthesis, reduces bone loss and length of surgery.

Ortho Development has designed the hip stem for use with its femoral heads and compatible acetabular components.

The hip stem includes a minimal broach-only instrumentation platform. It is available in a range of sizes with both standard and extended neck offset options in order to provide options for various patients needs.

According to the company, tapered stem design of the Ovation Tribute hip stem provides full rotational stability and promotes three-point fixation.

"The Ovation Tribute hip stem reduces bone loss and length of surgery."

In addition, the hip stem accommodates multiple surgical approaches, including the direct anterior approach with its new design features.

It is available in 12 sizes with standard and extended neck offsets to accommodate patient anatomy. Optimised neck geometry with highly polished surface improves overall range of motion and decreases wear.

Proximal body surface of the hip stem is coated with titanium plasma spray for solid, long-term fixation.

Ortho Development currently markets its products through a network of independent sales representatives and distributors in the US and through Japan Medical Dynamic Marketing in Japan.


Image: Ortho Development's Ovation Tribute hip stem for cementless use in total hip replacement and hemiarthroplasty procedures. Photo: courtesy of PRNews/Ortho Development Corporation.